Illness	Number of cases
Malignant neoplasm of prostate (C61)	401
Calculus of kidney and ureter - Calculus of ureter (N20.1)	399
Hyperplasia of prostate (N40)	303
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	234
Carcinoma in situ of other and unspecified sites - Carcinoma in situ of bladder (D09.0)	158
Calculus of kidney and ureter - Calculus of kidney (N20.0)	157
Unspecified haematuria (R31)	140
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	116
Obstructive and reflux uropathy (N13.3)	114
Other specified abnormalities of plasma proteins (R77.80)	105

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.2)	1.022
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	943
Insertion, exchange or removal of a ureteral stent (8-137.00)	505
Insertion, exchange or removal of a ureteral stent (8-137.10)	483
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	419
Ultrasound of the male reproductive organs with access through the urethra or anus (3-05c.0)	295
Operation using a surgical robot (5-987.0)	283
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	227
(9-984.7)	224
(1-465.91)	222

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Brustkrebs

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ05

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
160	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
107	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
105	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies
Lectureships / teaching posts at universities of applied sciences
Project-related cooperation with colleges and universities
Participation in multi-centre Phase I/II studies	Phase II-Studien
Doctoral supervision

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)
HB03	Physical therapist / physiotherapist (m/f)	Praxiseinsätze für Auszubildende der Physiotherapie in Zusammenarbeit mit "DIE SCHULE für Berufe mit Zukunft IFBE med. GmbH" Köln und SRH Fachschule für Physiotherapie, Leverkusen
HB07	Surgical technical assistant (m/f)
HB02	Health and paediatric nurse (m/f)
HB10	Midwife (m/f)	Praxispartner im Bereich des Hebammenstudiums der Fliedner Hochschule in Düsseldorf (Hebammenkunde, B.Sc. - Fliedner Fachhochschule)
HB19	Nursing professionals
HB15	Anaesthesia technical assistant (m/f)